Review



fmlp receptor expression  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 92
      Buy from Supplier

    Structured Review

    Miltenyi Biotec fmlp receptor expression
    FIGURE 3 | <t>fMLP</t> <t>receptor</t> expression by cPMNs and oPMNs. Quantitative analysis of fMLP receptor expression (percentages) of cPMNs (white bar) and oPMNs (gray bar). The gating strategy as presented in Supplementary Figure 2 was followed. Data are presented as mean (+SEM) percentages of fMLP receptor expression of the live, CD16+ population. n = 3, ***p < 0.0005.
    Fmlp Receptor Expression, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fmlp+receptor+expression/pm30984197-88-2-15?v=Miltenyi+Biotec
    Average 92 stars, based on 3 article reviews
    fmlp receptor expression - by Bioz Stars, 2026-08
    92/100 stars

    Images

    1) Product Images from "Oral Neutrophils Characterized: Chemotactic, Phagocytic, and Neutrophil Extracellular Trap (NET) Formation Properties."

    Article Title: Oral Neutrophils Characterized: Chemotactic, Phagocytic, and Neutrophil Extracellular Trap (NET) Formation Properties.

    Journal: Frontiers in immunology

    doi: 10.3389/fimmu.2019.00635

    FIGURE 3 | fMLP receptor expression by cPMNs and oPMNs. Quantitative analysis of fMLP receptor expression (percentages) of cPMNs (white bar) and oPMNs (gray bar). The gating strategy as presented in Supplementary Figure 2 was followed. Data are presented as mean (+SEM) percentages of fMLP receptor expression of the live, CD16+ population. n = 3, ***p < 0.0005.
    Figure Legend Snippet: FIGURE 3 | fMLP receptor expression by cPMNs and oPMNs. Quantitative analysis of fMLP receptor expression (percentages) of cPMNs (white bar) and oPMNs (gray bar). The gating strategy as presented in Supplementary Figure 2 was followed. Data are presented as mean (+SEM) percentages of fMLP receptor expression of the live, CD16+ population. n = 3, ***p < 0.0005.

    Techniques Used: Expressing



    Similar Products

    fmlp receptor expression  (Miltenyi Biotec)
    92
    Miltenyi Biotec fmlp receptor expression
    FIGURE 3 | <t>fMLP</t> <t>receptor</t> expression by cPMNs and oPMNs. Quantitative analysis of fMLP receptor expression (percentages) of cPMNs (white bar) and oPMNs (gray bar). The gating strategy as presented in Supplementary Figure 2 was followed. Data are presented as mean (+SEM) percentages of fMLP receptor expression of the live, CD16+ population. n = 3, ***p < 0.0005.
    Fmlp Receptor Expression, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fmlp+receptor+expression/pm30984197-88-2-15?v=Miltenyi+Biotec
    Average 92 stars, based on 1 article reviews
    fmlp receptor expression - by Bioz Stars, 2026-08
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    FIGURE 3 | fMLP receptor expression by cPMNs and oPMNs. Quantitative analysis of fMLP receptor expression (percentages) of cPMNs (white bar) and oPMNs (gray bar). The gating strategy as presented in Supplementary Figure 2 was followed. Data are presented as mean (+SEM) percentages of fMLP receptor expression of the live, CD16+ population. n = 3, ***p < 0.0005.

    Journal: Frontiers in immunology

    Article Title: Oral Neutrophils Characterized: Chemotactic, Phagocytic, and Neutrophil Extracellular Trap (NET) Formation Properties.

    doi: 10.3389/fimmu.2019.00635

    Figure Lengend Snippet: FIGURE 3 | fMLP receptor expression by cPMNs and oPMNs. Quantitative analysis of fMLP receptor expression (percentages) of cPMNs (white bar) and oPMNs (gray bar). The gating strategy as presented in Supplementary Figure 2 was followed. Data are presented as mean (+SEM) percentages of fMLP receptor expression of the live, CD16+ population. n = 3, ***p < 0.0005.

    Article Snippet: To investigate fMLP receptor expression, cells were stained with FITC-conjugated anti-human fMLP receptor (clone REA169, Miltenyi Biotec, Bergisch Gladbach, Germany) or FITC-labeled anti-human IgG1κ (clone MOPC-21, BD Biosciences) as an isotype control.

    Techniques: Expressing